Trial Profile
Abuse liability trial of abuse-resistant oxycodone in susceptible volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jul 2019
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Cassava Sciences; Pain Therapeutics
- 14 May 2016 Results (n=60) of drug abuse potential of REMOXY versus Oxycodone (IR) presented at the 35th Annual Scientific Meeting of the American Pain Society
- 21 May 2011 Results presented at the 30th Annual Scientific Meeting of the American Pain Society.
- 27 Apr 2011 New trial record